Organisatie
nucleaire geneeskunde
Huidige onderzoekers
31 - 35 of 35 results
- Mathieu Struys (Lid)
- John Van Naemen (Lid)
- Eva Vanelslande (Lid)
- Ilse Vaneycken (Lid)
- Lena Wimana (Lid)
Publicaties
1 - 10 van 105
- Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in belgium
Auteurs: J P Mulkay, Sophie Bourgeois, Luc Lasser, Chantal de Galocsy, S Tomasovic, Y. Horsmans, , Hendrik Reynaert
Pagina's: 30-40 - Pretreatment fluorodeoxyglucose positron emission tomography as predictive factor for the outcome of head and neck cancer patients.(2009)
Auteurs: Ashraf Farrag, Gaetane Ceulemans, Maria Voordeckers, Hendrik Everaert, Guy Storme
Pagina's: 477-477 - (18)F-FDG PET/CT imaging of an anti-CTLA-4 antibody-associated autoimmune pancolitis(2011)
Auteurs: Lode Goethals, Sofie Wilgenhof, F. De Geeter, Hendrik Everaert, Bart Neyns
Pagina's: 1390-1391 - Evaluation of different types of lithium fluoride thermoluminescent detectors for ring dosimetry in nuclear medicine(2022)
Auteurs: Olivier Van Hoey, Hasan Moudud, Lara Struelens, Werner Schoonjans, Jeremie Dabin, Dayana Castillo, Sonja Van den Block, Filip Vanhavere
- Radiolabeled single-domain antibodies as a means to evoke and monitor immunological responses in malignant lesions(2023)
Auteurs: Thomas Ertveldt, Karine Breckpot, Matthias D'Huyvetter, Marleen Keyaerts, Nick Devoogdt
Aantal pagina's: 177 - Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells(2019)
Auteurs: Inès Dufait, Julian Pardo, David Escors, Yannick De Vlaeminck, H. Jiang, Marleen Keyaerts, Mark De Ridder, Karine Breckpot
- An interpretable deep learning approach for lesion detection and segmentation on whole-body [18F]FDG PET/CT(2024)Volume: 12926
Auteurs: Ine Dirks, Marleen Keyaerts, Bart Neyns, Jef Vandemeulebroucke
Aantal pagina's: 10 - Undetectable thyroglobulin makes 123I whole-body scan and stimulated thyroglobulin obsolete in follow-up care of differentiated thyroid cancer(2021)
Auteurs: Bastiaan Sol, Bert Bravenboer, Brigitte Velkeniers-Hoebanckx, Steven Raeymaeckers, Marleen Keyaerts, Corina Andreescu
- Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.(2015)
Auteurs: Kristoff Muylle, P. Flamen, DJ Vugts, T Guiot, G Ghanem, N Meuleman, P Bourgeois, B Vanderlinden, GAMS van Dongen, M Vaes, et al.
Pagina's: 1304-1314 - Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer.(2020)
Auteurs: Yana Dekempeneer, Vicky Caveliers, Maarten Ooms, Dominic Maertens, Mireille Gysemans, Tony Lahoutte, Catarina Xavier, Quentin Lecocq, Ken Maes, Peter Covens, et al.
Pagina's: 3553-3566